PGR and cancer: The fact that these parameters showed significant associations with ER/PR-negative cancer may assist in the development of new treatment options; improving treatment for these individuals is critical because of the generally poorer prognosis of ER/PR-negative cancer and the inapplicability of adjuvant endocrine therapy.